BioSyntech Inc.

MUMBAI - India’s Piramal Lifesciences , the research unit of Piramal Enterprises Ltd. , has trimmed its discovery research portfolio, focusing sharply on developing newer candidates to go as “comp

MUMBAI – Six years after its first investment in an innovative bio-orthopedic product for cartilage repair developed by Montreal-based BioSyntech Inc. , India’s Piramal Enterprises Ltd. announc

by Sharon O'Reilly The musculoskeletal sector continues to be bogged down by the economic downturn, and particularly hard hit is the industry's largest segment—the $13 billion total joint market. Acro

by Sharon O’Reilly With the era of regenerative medicine upon us, fueled in part by the Obama administration’s lifting of the ban on government funding for stem cell research, advancements in biologic